Home » Topics » Regulatory » EMA

EMA
RSS

Trastuzumab emtansine receives committee recommendation in E.U.

Sep. 23, 2013

CHMP recommends E.U. approval of canagliflozin

Sep. 23, 2013

Novo Nordisk's NovoEight gets positive opinion in E.U.

Sep. 23, 2013

Otsuka and Lundbeck receive positive CHMP opinion for Abilify Maintena

Sep. 23, 2013

EMA committee issues positive opinion on AstraZeneca's four-strain flu vaccine

Sep. 23, 2013

Relvar Ellipta receives approval in Japan, recommendation in Europe

Sep. 20, 2013

EMA grants orphan drug status to GMI-1070 in sickle cell disease

Sep. 17, 2013

EMA grants orphan drug designation to Patrys antibody for multiple myeloma

Sep. 12, 2013

EMA extends review of Clinuvel's SCENESSE to January 2014

Aug. 6, 2013

Novartis receives positive CHMP opinion for Ilaris in systemic juvenile idiopathic arthritis

July 31, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Jiangsu Nhwa Pharmaceutical patents new κ-opioid receptor antagonists
BioWorld Science
Jiangsu Nhwa Pharmaceutical Co. Ltd. has disclosed κ-opioid receptor antagonists that are potentially useful for the treatment of neurological disorders.